Georgia Mesothelioma Doctors, Cancer Centers and Treatment

Mesothelioma patients who live in Georgia have access to quality mesothelioma treatment options in state. Conventional mesothelioma treatments available in Georgia include surgery, chemotherapy and radiation. Beyond these conventional treatments, clinical trials may currently be recruiting pleural and peritoneal mesothelioma patients in Georgia.

We provide a list of top mesothelioma doctors that practice in Georgia as well as the top cancer care centers in the state. A list of local cancer support services has been included as well for your convenience. Learn more about health care options available to you in Georgia here.

Find a Mesothelioma Cancer Center in Georgia

We have compiled a list of mesothelioma cancer centers in Georgia. Please click on a cancer center link for more information about the clinical programs offered, affiliated mesothelioma doctors and how to contact the cancer center.

Doctors who Treat Mesothelioma in Georgia

We have compiled a list of mesothelioma doctors that practice in the state of Georgia. Please click on a doctor link to obtain more information about his/her background, areas of expertise, professional affiliations, and office locations.

Occasionally, mesothelioma patients will travel to other states to meet with top mesothelioma doctors and thoracic surgeons across the country. These experts will usually concentrate on a particular mesothelioma type within their practice.

Mesothelioma Clinical Trials in Georgia

The following clinical trials are in progress or actively recruiting participants in the state of Georgia:

• A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

  Conditions:	Melanoma; Breast Carcinoma; Hepatocellular Carcinoma; Urothelial Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Non-small Cell Lung Carcinoma; Gastric or Gastroesophageal Junction Adenocarcinoma; Endometrial Carcinoma; Mesothelioma; Neuroendocrine Carcinoma; Cervical Cancer; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of the Anus
  Last Updated:	April 29, 2019
  Status:	Recruiting
  Locations:	Atlanta, GA. Los Angeles, CA. San Diego, CA. San Francisco, CA. Chicago, IL. Fairway, KS. Detroit, MI. New York, NY. Portland, OR. Philadelphia, PA.

• Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

  Conditions:	Unresectable Pleural or Peritoneal Malignant Mesothelioma
  Last Updated:	March 18, 2019
  Status:	Active, not recruiting
  Locations:	Augusta, GA. Scottsdale, AZ. La Jolla, CA. Los Angeles, CA. San Francisco, CA. Santa Monica, CA. New Haven, CT. Newark, DE. Tampa, FL. Chicago, IL.

• Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:	Epithelioid Mesothelioma; Pleural Malignant Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatoid Mesothelioma
  Last Updated:	January 16, 2019
  Status:	Active, not recruiting
  Locations:	Gainesville, GA. Rogers, AR. Antioch, CA. Burbank, CA. Fremont, CA. Fresno, CA. Los Angeles, CA. Modesto, CA. Oakland, CA. Orange, CA.

• A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

  Conditions:	Advanced Solid Tumors (Part A/B/C/D); Non-small Cell Lung Cancer (Part E); Melanoma (Part E); Squamous Cell Cancer of the Head and Neck (Part E); Triple Negative Breast Cancer (Part F); Adrenocortical Carcinoma (Part G); Mesothelioma (Part G); High-circulating Myeloid-derived Suppressor Cells (Part H)
  Last Updated:	September 11, 2018
  Status:	Recruiting
  Locations:	Atlanta, GA. San Diego, CA. Santa Monica, CA. Port Saint Lucie, FL. Boston, MA. Hackensack, NJ. New York, NY. Houston, TX. San Antonio, TX.

• Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

  Conditions:	Solid Tumors; Triple-Negative Breast Cancer; Non Small Cell Lung Cancer; Renal Cell Carcinoma; Mesothelioma; Fumarate Hydratase (FH)-Deficient Tumors; Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST); Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors; Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations; Tumors Harboring Amplifications in the cMyc Gene
  Last Updated:	July 18, 2018
  Status:	Active, not recruiting
  Locations:	Atlanta, GA. San Francisco, CA. Stanford, CA. Sarasota, FL. Bethesda, MD. Boston, MA. New York, NY. Philadelphia, PA. Nashville, TN. Houston, TX.

Locate Cancer Support Services in Georgia

Cancer support services for mesothelioma patients include patient transport, temporary housing, physical therapy and counseling. The following local services may be of help to you while you are receiving treatment for mesothelioma in Georgia.

Financial Assistance Available for Mesothelioma Victims

Help provide security for loved ones.